DXB 0.88% 56.5¢ dimerix limited

DXB - Research & Valuation, page-131

  1. 716 Posts.
    lightbulb Created with Sketch. 72
    I think it could do really well as more regional deals are realised and it can settle in a very nice range for shareholders. Everything ultimately depends on trial results which are not yet fully guaranteed.

    My longer term hope is for their dmx700 pipeline for chronic obstructive pulmonary disease (COPD) which is horribly debilitating for sufferers and distressing to witness. (I need to update myself exactly where it's at trial-wise.)

    Based solely on my own thoughts successful treatment of COPD would multiply the company value several times beyond where it will settle for FSGS success only.
    Definitely a longer term hope.
    dyor - not financial advice - my musings only

 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
56.5¢
Change
-0.005(0.88%)
Mkt cap ! $313.3M
Open High Low Value Volume
56.0¢ 58.5¢ 54.0¢ $2.643M 4.723M

Buyers (Bids)

No. Vol. Price($)
12 93440 56.0¢
 

Sellers (Offers)

Price($) Vol. No.
57.0¢ 78909 4
View Market Depth
Last trade - 14.51pm 19/06/2024 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.